Targeting Glioblastoma: Efficacy of Ruthenium-Based Drugs.

Puthiyavalappil RasinSravan Sangeeth SurendranKarthik K SJebiti Haribabu Anandaram Sreekanth

Published in: Chemical research in toxicology (2024)

Ruthenium compounds offer improved selectivity and fewer side effects compared to platinum-based drugs in glioblastoma treatment. Insights into their interactions with transferrin suggest targeted drug delivery, while photoactivated chemotherapy is a novel cytotoxic approach in tumor tissues.

Keyphrases

cancer therapy
drug delivery
drug induced
combination therapy
replacement therapy
rectal cancer